Effects of interleukin-2 on hepatitis B vaccination in uraemic patients.
G J
GJ
Boland
G C
GC
de Gast
J
J
van Hattum
D006509:Hepatitis B / Q000517:prevention & control; D006510:Hepatitis B Antibodies / Q000096:biosynthesis; D017325:Hepatitis B Vaccines / Q000276:immunology*; D006801:Humans; D007376:Interleukin-2 / Q000494:pharmacology*; D006435:Renal Dialysis; D014511:Uremia / Q000276:immunology* / Q000628:therapy
D006510:Hepatitis B Antibodies; D017325:Hepatitis B Vaccines; D007376:Interleukin-2